Nedometinib

Modify Date: 2024-04-09 18:42:11

Nedometinib structure	Common Name	Nedometinib
	CAS Number	2252314-46-6	Molecular Weight	470.24
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₇H₁₆FIN₄O₃	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Nedometinib

Nedometinib is a tyrosine kinase inhibitor targeting to MEK1. Nedometinib has antineoplastic effect and can be used for research in dermatosis, cutaneous fibroneuroma, neurofibromatosis[1].

Name	Nedometinib

Description	Nedometinib is a tyrosine kinase inhibitor targeting to MEK1. Nedometinib has antineoplastic effect and can be used for research in dermatosis, cutaneous fibroneuroma, neurofibromatosis[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> MAPK/ERK Pathway >> MEK
Target	MEK1[1]
References	[1]. Kincaid, et al. Preparation of pyrrolopyridine-aniline compounds for treatment of dermal disorders. World Intellectual Property Organization, WO2018213810 A1. 2018-11-22.

Molecular Formula	C₁₇H₁₆FIN₄O₃
Molecular Weight	470.24

Dichloromethane
CAS#:75-09-2

Polyacrylic acid
CAS#:9003-01-4

sodium carbonate
CAS#:497-19-8

Silicon dioxide
CAS#:7631-86-9

Triethanolamine
CAS#:102-71-6

Demeton
CAS#:126-75-0

Water
CAS#:7732-18-5

4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9

Diclofenac sodium
CAS#:15307-79-6

Budesonide
CAS#:51372-29-3

Nedometinib

Use of Nedometinib

Names

Nedometinib Biological Activity

Chemical & Physical Properties